Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

5 Jun 2006 15:44

Ark Therapeutics Group PLC05 June 2006 Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Unapproved Share Option Scheme (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) (amount of stock/debt security) not issued under the Scheme 907,401 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period 36,250 6. Balance under the Scheme not yet issued/allotted at end of period 871,151 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Enterprise Management Incentive Share Option Plan (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) amount of stock/debt security) not issued under the Scheme 277,016 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period Nil 6. Balance under the Scheme not yet issued/allotted at end of period 277,016 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Apr 20093:34 pmRNSAGM Results
7th Apr 200911:09 amRNSAnnual Information Update
7th Apr 20097:00 amRNSResearch Update
17th Mar 20095:03 pmRNSHolding(s) in Company
13th Mar 20094:25 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSFinal Results
2nd Mar 200911:21 amRNSVoting Rights and Capital
26th Feb 20097:00 amRNSPatent Filing
17th Feb 20092:14 pmRNSHolding(s) in Company
16th Feb 20095:39 pmRNSHolding(s) in Company
16th Feb 20097:00 amRNSResearch Update
5th Feb 200910:50 amRNSDealing by Employee Benefit Trust
2nd Feb 20097:00 amRNSDirector/PDMR Shareholding
21st Jan 20094:40 pmRNSSecond Price Monitoring Extn
21st Jan 20094:37 pmRNSPrice Monitoring Extension
21st Jan 200912:12 pmRNSNotice of Results
14th Jan 20097:00 amRNSRe Agreement
9th Jan 200910:23 amRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrinam Phase III trial to commence
6th Jan 20097:00 amRNSResearch Update
31st Dec 20089:00 amRNSTotal Voting Rights
16th Dec 20083:46 pmRNSNotification of Major Interests in Shares
9th Dec 20084:40 pmRNSSecond Price Monitoring Extn
9th Dec 20084:35 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSRegulatory Approval
5th Dec 20082:28 pmRNSBlocklisting Six Monthly Return
1st Dec 20087:00 amRNSRegulatory Application
24th Nov 200811:58 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSInterim Management Statement
20th Oct 20087:00 amRNSProduct Launch
2nd Oct 20087:00 amRNSArk secures reimbursement for Neuropad
30th Sep 20085:06 pmRNSVoting Rights and Capital
17th Sep 20081:08 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
27th Aug 20087:00 amRNSResearch Update
26th Aug 20084:08 pmRNSHolding(s) in Company
1st Aug 200810:47 amRNSVoting Rights and Captial
31st Jul 20081:12 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSResearch Update
16th Jul 20087:00 amRNSResearch Update
8th Jul 200811:00 amRNSArk opens new manufacturing f
24th Jun 200811:28 amRNSHolding(s) in Company
18th Jun 20087:00 amRNSResearch Update
6th Jun 200812:10 pmRNSBlocklisting Application
3rd Jun 200810:58 amRNSBlocklisting Interim Review
3rd Jun 200810:51 amRNSBlocklisting Interim Review
2nd Jun 20087:00 amRNSRegulatory Approval
30th May 20084:52 pmRNSVoting Rights and Capital
30th May 20087:00 amRNSResearch Update
22nd May 20081:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.